MustGrow BiologicsMGROF -0.61%29 EBITDA Margin % is -880.28% as of Mar. 2026. GuruFocus rates MGROF with a GF Score™ of 29/100. The stock has 3 warning signs investors should review. Among 251 Agriculture companies, MustGrow Biologics ranks worse than 97.21% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. MustGrow Biologics's EBITDA for the
three
months ended in Mar. 2026 was $-0.63 Mil. MustGrow Biologics's Revenue for the
three
months ended in Mar. 2026 was $0.07 Mil. Therefore, MustGrow Biologics's EBITDA margin for the quarter that ended in Mar. 2026 was -880.28%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
MustGrow Biologics EBITDA Margin % Related Terms
MustGrow Biologics EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for MustGrow Biologics's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MGROF vs CTVA, CF, MOS: EBITDA Margin % Comparison
For the Agricultural Inputs subindustry, MustGrow Biologics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MustGrow Biologics EBITDA Margin % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, MustGrow Biologics's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where MustGrow Biologics's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MustGrow Biologics (MGROF) has a EBITDA Margin % of -880.28% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MustGrow Biologics and its competitors. According to the industry distribution chart, MustGrow Biologics ranks #244 out of 251 companies in the Agriculture industry, placing it in the top 97.2%.
Is MustGrow Biologics' EBITDA Margin % too high?
MustGrow Biologics' current EBITDA Margin % is -880.28%. Based on the distribution chart, MustGrow Biologics ranks #244 out of 251 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, MustGrow Biologics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does MustGrow Biologics' EBITDA Margin % compare to CTVA and CF?
According to the Agriculture industry distribution chart, MustGrow Biologics ranks #244 out of 251 companies for EBITDA Margin %. This places MustGrow Biologics in the lower half of its industry. The industry median EBITDA Margin % is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Agriculture company?
The median EBITDA Margin % among Agriculture companies is 9.60, based on 251 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on MustGrow Biologics and its competitors. For the Agriculture industry, the median EBITDA Margin % is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MustGrow Biologics's current EBITDA Margin % is -880.28%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MustGrow Biologics stock overvalued right now?
MustGrow Biologics (MGROF) has a current EBITDA Margin % of -880.28%. The current EBITDA Margin % is -880.28%. MustGrow Biologics' overall GF Score™ is 29/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For MustGrow Biologics (MGROF), the current EBITDA Margin % is -880.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MustGrow Biologics Corp is a fully integrated provider of biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. It offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, and foliar products. These products are synergistically distributed alongside MustGrow's wholly owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers.
29GF Score
Get the complete analysis for MGROF
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MGROF has been successfully added to your 
